AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....
AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....
AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
AstraZeneca PLC (NASDAQ: AZN) has recently witnessed a significant acquisition of shares by Hilltop Holdings Inc....
AstraZeneca PLC, a renowned pharmaceutical company, recently revealed its share capital details. This news has attracted the attention of investors worldwide....
AstraZeneca PLC (AZN) shares experienced a decline in value following reports of a probe by the People's Republic of China (PRC)....
Pathstone Holdings LLC has announced its intention to acquire AstraZeneca PLC, a leading pharmaceutical company specializing in immunotherapy....
AstraZeneca PLC, a leading global pharmaceutical company, is garnering attention from investors as it seeks to establish itself as a U.K. Dividend Champion by 2024....